Feiyan Liu
PhD candidate / gast
- Naam
- Dr. F. Liu
- Telefoon
- +31 71 527 2727
- f.liu@lacdr.leidenuniv.nl
PhD candidate / gast
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
- Liu F. (14 juni 2023), Quantitative pharmacological modelling for optimizing treatment of sepsis (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Promotor(en): Hasselt J.G.C. van & Graaf P.H. van der.
- Liu F., Aulin L.B.S. & Manson M.L. Krekels E.H.J. Hasselt J.G.C. van (2023), Unraveling the effects of acute inflammation on pharmacokinetics: a model-based analysis focusing on renal glomerular filtration rate and cytochrome P450 3A4-mediated metabolism, European Journal of Drug Metabolism and Pharmacokinetics 48: 623–631.
- Liu F., Aulin L.B.S., Guo T., Krekels E.H.J., Moerland M., Graaf P.H. van der & Hasselt J.G.C. van (2022), Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations, British Journal of Clinical Pharmacology 88(12): 5420-5427.
- Liu F., Aulin L.B.S., Kossen S.S.A., Cathalina J.E.J., Bremmer M., Foks A.C., Graaf P.H. van den Moerland M. & Hasselt J.G.C. van (2022), A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsis, Journal of Pharmacokinetics and Pharmacodynamics 49(6): 645-655.
- Thomson K.M., Dyer C., Liu F., Sands K., Portal E., Carvalho M.J., Barrell M., Boostrom I., Dunachie S., Farzana R., Ferreira A., Frayne F., Hassan B., Jones E., Jones L., Mathias J., Milton R., Rees J., Chan G.J., Bekele D., Mahlet A., Basu S., Nandy R.K., Saha B., Iregbu K., Modibbo F., Uwaezuoke S., Zahra R., Shirazi H., Syed N.U., Mazarati J.B., Rucogoza A., Gaju L., Mehtar S., Bulabula A.N.H., Whitelaw A., Hasselt J.G.C. van & Walsh T.R. (2021), Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS), Lancet Infectious Diseases 21(12): 1677-1688.